Select Medical Holdings Corporation SEM | NYSE

$15.13 -$0.12 | -0.79%

After Hours
$15.05 -$0.08 | -0.53%

Next Earnings: Jul 30, 2025

Company Overview:

Market Cap: $1.94B
PE Ratio: 24.4
52-Week Range: $14.03 - $22.08
Dividend Yield (FWD): 1.65% ($0.25)

6 Year SEM Performance Metrics:

Total Return (with DRIP): 4.2% (0.69% CAGR)
Total Return (no DRIP): 9.3% (1.49% CAGR)
Share Price: -3.1% (-0.53% CAGR)
Dividend Increase: -50.0% (-15.94% CAGR)
SEM 6-yr Total Return ($10K invested)
1Y 2Y 5Y 10Y

SEM Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
SEM Dividend CAGR:1Y: -50.00%2Y: -29.29%5Y: -8.97%10Y: N/A
Share Price
SEM Price CAGR:1Y: -58.16%2Y: -30.30%5Y: 0.92%10Y: -0.32%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$35/mo
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 20% OFF
$336/yr
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

SEM Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend Payout Ratio - SEM
7-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - SEM
7-Day FREE Trial Get Full Access Now!

SEM Earnings, Revenue, Cash & Debt, Shares Outstaning:

SEM - Revenue
7-Day FREE Trial Get Full Access Now!
SEM Revenue CAGR:1Y: -24.35%2Y: -9.85%5Y: -0.88%10Y: 5.46%
SEM - Earnings Per Share (EPS)
7-Day FREE Trial Get Full Access Now!
SEM EPS CAGR:1Y: -41.33%2Y: -11.36%5Y: 1.92%10Y: 5.00%
SEM - Net Income
7-Day FREE Trial Get Full Access Now!
SEM Net Income CAGR:1Y: -41.50%2Y: -10.53%5Y: 1.30%10Y: 4.92%
SEM - EBITDA
7-Day FREE Trial Get Full Access Now!
SEM EBITDA CAGR:1Y: -38.07%2Y: -13.20%5Y: -2.64%10Y: 3.65%
SEM - Free Cash Flow
7-Day FREE Trial Get Full Access Now!
SEM Free Cash Flow CAGR:1Y: -53.19%2Y: 173.76%5Y: N/A10Y: N/A
SEM - Free Cash Flow / Share
7-Day FREE Trial Get Full Access Now!
SEM Free Cash Flow / Share CAGR:1Y: -53.48%2Y: 171.49%5Y: N/A10Y: N/A
SEM - Operating Income
7-Day FREE Trial Get Full Access Now!
SEM Operating Income CAGR:1Y: -41.18%2Y: -13.72%5Y: -2.61%10Y: 3.59%
SEM - Gross Profit
7-Day FREE Trial Get Full Access Now!
SEM Gross Profit CAGR:1Y: -24.81%2Y: 0.00%5Y: 0.00%10Y: 0.00%
SEM - Shares Outstanding
7-Day FREE Trial Get Full Access Now!
SEM Shares Outstanding CAGR:1Y: 0.61%2Y: 0.84%5Y: -1.56%10Y: -0.26%
SEM - Share Buybacks
7-Day FREE Trial Get Full Access Now!
SEM Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 5.56%10Y: 0.00%
SEM - Stock-Based Comp
7-Day FREE Trial Get Full Access Now!
SEM Stock-Based Comp CAGR:1Y: -66.48%2Y: -38.17%5Y: -10.83%10Y: 4.96%
SEM - Expenses
7-Day FREE Trial Get Full Access Now!
SEM Expenses CAGR:1Y: -0.34%2Y: -5.72%5Y: 5.95%10Y: 6.51%
SEM - Revenue vs Net Income
7-Day FREE Trial Get Full Access Now!
SEM - EPS vs FCF / Share
7-Day FREE Trial Get Full Access Now!
SEM - EPS vs PE Ratio
7-Day FREE Trial Get Full Access Now!
SEM - FCF vs FCF / Share
7-Day FREE Trial Get Full Access Now!
SEM - FCF vs Stock Based Comp
7-Day FREE Trial Get Full Access Now!
SEM - Cash & Debt
7-Day FREE Trial Get Full Access Now!
SEM - Dividends
7-Day FREE Trial Get Full Access Now!
SEM Dividend CAGR:1Y: -50.00%2Y: -29.29%5Y: -8.97%10Y: N/A
SEM - Revenue by Segment
7-Day FREE Trial Get Full Access Now!
SEM Revenue CAGR:1Y: -24.35%2Y: -9.85%5Y: -0.88%10Y: 5.46%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

SEM - REVENUE: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
SEM Actual Revenue CAGR:1Y: -24.35%2Y: -9.85%5Y: -0.88%10Y: 5.46%
SEM - EPS: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
SEM Actual EPS CAGR:1Y: -41.33%2Y: -11.36%5Y: 1.92%10Y: 5.00%
SEM - NET INCOME: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
SEM Actual Net Income CAGR:1Y: -41.50%2Y: -10.53%5Y: 1.30%10Y: 4.92%
SEM - EBITDA: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
SEM Actual EBITDA CAGR:1Y: -38.07%2Y: -13.20%5Y: -2.64%10Y: 3.65%

Ratios, Profit Margins & Return on Capital:

SEM - Net Profit Margin
7-Day FREE Trial Get Full Access Now!
SEM Net Profit Margin CAGR:1Y: -22.69%2Y: -0.71%5Y: 2.19%10Y: -0.51%
SEM - Gross Profit Margin
7-Day FREE Trial Get Full Access Now!
SEM Gross Profit Margin CAGR:1Y: -0.60%2Y: -5.00%5Y: -2.51%10Y: -2.09%
SEM - Price to Earnings
7-Day FREE Trial Get Full Access Now!
SEM - Price To Sales Ratio
7-Day FREE Trial Get Full Access Now!
SEM - Return on Capital Employed
7-Day FREE Trial Get Full Access Now!
SEM - Return on Invested Capital
7-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

SEM Dividends Info:

Annual Dividend: $0.25
Forward Yield: 1.65%
Ex-Dividend Date: 2025-05-15
Lifetime Dividends / Share: $4.24

SEM Dividend History: Dates, Payments & Yield list

Below is a schedule of all SEM dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
05/15/202505/29/2025$0.0632.08%1.65%$15.17
03/03/202503/13/2025$0.0632.12%1.51%$16.58
11/13/202411/26/2024$0.0671.16%1.26%$21.34
08/14/202408/30/2024$0.1251.56%1.39%$36.07
05/15/202405/30/2024$0.1251.43%1.47%$33.91
02/29/202403/13/2024$0.1251.84%1.75%$28.59
11/14/202311/28/2023$0.1252.16%2.19%$22.88
08/14/202309/01/2023$0.1251.75%1.72%$29.06
05/17/202305/31/2023$0.1251.78%1.83%$27.37
03/02/202303/15/2023$0.1251.87%2%$25.05
11/15/202211/29/2022$0.1252.03%2.09%$23.93
08/15/202209/02/2022$0.1251.8%1.99%$25.13
05/18/202206/01/2022$0.1252.04%2.07%$24.15
03/03/202203/16/2022$0.1252.1%2.04%$24.55
11/15/202111/29/2021$0.1251.12%1.78%$28.10
08/17/202108/30/2021$0.1250.72%1.44%$34.80
05/18/202106/01/2021$0.1250.33%1.25%$40.10
03/02/201503/11/2015$0.1000%2.56%$15.62
11/17/201412/01/2014$0.1000%2.56%$15.62
08/18/201408/29/2014$0.1000%2.56%$15.62
05/14/201405/28/2014$0.1000%2.56%$15.62
02/27/201403/10/2014$0.1000%2.56%$15.62
11/07/201311/22/2013$0.1000%2.56%$15.62
08/16/201308/30/2013$0.1000%2.56%$15.62
05/16/201305/30/2013$0.1000%2.56%$15.62
12/03/201212/12/2012$1.5000%38.41%$15.62

Projected Future Returns & Dividends for SEM

Based on past 6-year performance, here are SEM growth metrics:

Share price CAGR of -0.53%
Dividend CAGR of -4.59%

Using SEM CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

SEM (DRIP)SEM - No DRIP
Current Price$15.13$15.13
Start Shares660.94660.94
Start Value$10,000$10,000
  
After 10 years:
Final Share Count758.52660.94
Dividends Payment$0.04$0.04
Annual Dividends$119$103
Yield on cost1.19%1.03%
Share Price$14.42$14.42
Total Dividends$1,444$1,350
Final Value$10,941$10,883

Estimated Future Value + Dividends - SEM

NOTE: Above numbers are our estimate based on SEM's Dividend and Price CAGR over past 6 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Monthly
$35/mo
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 20% OFF
$336/yr
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Company Info

Select Medical Holdings Corporation (SEM) had its IPO on 2009-09-25, and is trader on NYSE stock exchange.

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma. Its Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including rehabilitative services for brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic conditions, pediatric congenital or acquired disabilities, and cancer. The company's Outpatient Rehabilitation segment operates rehabilitation clinics that provide physical, occupational, and speech rehabilitation programs and services; and specialized programs, such as functional programs for work related injuries, hand therapy, post-concussion rehabilitation, pediatric and cancer rehabilitation, and athletic training services. Its Concentra segment operates and provides occupational health centers and contract services at employer worksites that deliver occupational medicine, consumer health, physical therapy, and wellness services. As of December 31, 2021, the company operated 104 critical illness recovery hospitals in 28 states; 30 rehabilitation hospitals in 12 states; 1,881 outpatient rehabilitation clinics in 38 states and the District of Columbia; and 518 occupational health centers in 41 states, and 134 onsite clinics at employer worksites states. Select Medical Holdings Corporation was founded in 1996 and is headquartered in Mechanicsburg, Pennsylvania.

SEM website: https://www.selectmedical.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$35/mo
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 20% OFF
$336/yr
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial